Search details
1.
Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion.
J Cutan Pathol
; 51(6): 419-423, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38468567
2.
Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review.
J Cutan Pathol
; 51(6): 407-414, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38444194
3.
Clinicopathologic Features of Therapy-Related Myeloid Neoplasms in Patients with Myeloma in the Era of Novel Therapies.
Mod Pathol
; 36(6): 100166, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36990279
4.
Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort.
Am J Obstet Gynecol
; 224(3): 278.e1-278.e14, 2021 03.
Article
in English
| MEDLINE | ID: mdl-32835719
5.
A Cryptic BCR-PDGFRB Fusion Resulting in a Chronic Myeloid Neoplasm With Monocytosis and Eosinophilia: A Novel Finding With Treatment Implications.
J Natl Compr Canc Netw
; 18(10): 1300-1304, 2020 10.
Article
in English
| MEDLINE | ID: mdl-33022638
6.
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.
Cancer Immunol Immunother
; 67(10): 1647-1658, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30073390
7.
Non-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis.
Am J Hematol
; 97(3): E100-E102, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34989420
8.
Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention.
J Immunol
; 189(5): 2656-64, 2012 Sep 01.
Article
in English
| MEDLINE | ID: mdl-22844125
9.
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
Cancers (Basel)
; 16(9)2024 Apr 27.
Article
in English
| MEDLINE | ID: mdl-38730662
10.
Clinical and genomic landscape of RAS mutations in gynecologic cancers.
Clin Cancer Res
; 2024 Apr 30.
Article
in English
| MEDLINE | ID: mdl-38687597
11.
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival.
Cancer Immunol Immunother
; 62(8): 1303-13, 2013 Aug.
Article
in English
| MEDLINE | ID: mdl-23661160
12.
Müllerian-Type Clear Cell Carcinoma of Donor Origin in a Male Patient with a Kidney Transplant: Ascertained by Molecular Testing.
Curr Oncol
; 30(10): 9019-9027, 2023 10 05.
Article
in English
| MEDLINE | ID: mdl-37887551
13.
Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma.
Life (Basel)
; 13(11)2023 Nov 10.
Article
in English
| MEDLINE | ID: mdl-38004332
14.
Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Clin Cancer Res
; 29(23): 4844-4852, 2023 12 01.
Article
in English
| MEDLINE | ID: mdl-37747813
15.
Intragenic EGFR::EGFR.E1E8 Fusion (EGFRvIII) in 4331 Solid Tumors.
Cancers (Basel)
; 16(1)2023 Dec 19.
Article
in English
| MEDLINE | ID: mdl-38201434
16.
Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effects.
Cancer Immunol Immunother
; 61(10): 1683-97, 2012 Oct.
Article
in English
| MEDLINE | ID: mdl-22392192
17.
Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods.
Cancers (Basel)
; 14(19)2022 Sep 20.
Article
in English
| MEDLINE | ID: mdl-36230473
18.
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.
Cancer Immunol Immunother
; 60(5): 731-8, 2011 May.
Article
in English
| MEDLINE | ID: mdl-21340652
19.
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Pediatr Blood Cancer
; 57(3): 398-405, 2011 Sep.
Article
in English
| MEDLINE | ID: mdl-21681921
20.
TP53 variant allele frequency correlates with the chemotherapy response score in ovarian/fallopian tube/peritoneal high-grade serous carcinoma.
Hum Pathol
; 115: 76-83, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34153306